Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
about
Caenorhabditis elegans HCF-1 functions in longevity maintenance as a DAF-16 regulatorSirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcriptionInteractions between E2F1 and SirT1 regulate apoptotic response to DNA damageNovel repressor regulates insulin sensitivity through interaction with Foxo1Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradationThe LIM-only protein FHL2 is a negative regulator of E4F1The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXOHormesis: Decoding Two Sides of the Same CoinRedox regulation of FoxO transcription factorsProtective effects and mechanisms of sirtuins in the nervous systemSirtuin 1 and sirtuin 3: physiological modulators of metabolismThe role of mammalian sirtuins in the regulation of metabolism, aging, and longevitySirtuins in hematological aging and malignancyDiverse roles of SIRT1 in cancer biology and lipid metabolismModulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activityThe emerging roles of forkhead box (Fox) proteins in cancerThe FoxO codeProline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assemblySIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgammaNAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicitySIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivoMultiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cellsThe intersection between DNA damage response and cell death pathwaysSIRT1 is a critical regulator of K562 cell growth, survival, and differentiationSirtuins in mammals: insights into their biological functionFOXO transcription factors at the interface between longevity and tumor suppressionCancer biomarker discovery: the entropic hallmark.A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.SIRT1 top 40 hits: use of one-bead, one-compound acetyl-peptide libraries and quantum dots to probe deacetylase specificity.FoxO transcription factors in oxidative stress response and ageing--a new fork on the way to longevity?The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivoHuman sirt-1: molecular modeling and structure-function relationships of an unordered protein.VANLO--interactive visual exploration of aligned biological networksSirt1 carboxyl-domain is an ATP-repressible domain that is transferrable to other proteins.Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.Shear stress, SIRT1, and vascular homeostasis.Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts
P2860
Q21145855-84B73A65-E060-4EB8-A56A-5179695A2F5FQ21296795-E7D1C8D1-D173-46F6-A425-34945EC81318Q24299098-70D367C3-92CC-4400-BBC1-039806671FD2Q24314731-10D3B06E-ECB6-4358-95AE-E3E095CA0C47Q24322745-F27A12D8-075F-4FD2-AAAE-DC3EC4E5E9C3Q24323174-23CF5AE3-66C5-494C-822E-1F4AF83389A0Q24337665-4A5B8B59-C785-4977-BCEF-89B5F4FBAE06Q26773354-018263B7-2A61-4354-8749-42F44975F305Q26799843-F023E91A-84BD-4224-B153-FE543E596025Q26825585-F3444221-0153-419B-87B5-F805528575C7Q26828607-8C7D3C5E-3968-4C06-B28E-D96918A07A77Q26865526-3882236A-E15C-4AF4-959F-F46CFF02C083Q26991467-2982A3BA-646A-41AF-8BEC-D9444C3433E3Q26997827-05CCE213-CDDB-4F25-A3F2-3E73583F9619Q27330338-893EA4A8-D3D5-474D-9EF5-3D933594936FQ28253741-76A9AF46-5280-4210-B0A0-EE3EA34ACB62Q28275268-23558A4D-1DA2-451E-820F-C7993D5522E4Q28280935-3CCF7DB3-8264-4620-B033-CFF7A0EEE919Q28291221-DFBD7534-E638-4CBF-8326-7D79C70FF26DQ28301961-EFEDB360-26F5-4730-842E-DCD22BC70E35Q28476267-978980E5-EDB6-4CC5-8870-91C2125B66EAQ28482270-ED11EF0A-2853-4F93-8179-8C8850104EE8Q28577088-008A5A88-44D4-4E02-9D6A-D67480401511Q28611423-B93FC8FF-9929-49F9-BDF8-D5AF89F95B2FQ29391242-54915138-B970-4053-8174-2D88E43F57F6Q29615248-E0BFF123-1782-490A-917C-E22DCA523A0CQ29620472-303D6B30-B359-43C0-AB90-ED722D599665Q30496149-B4D891E2-227F-4C0B-8F52-79ABBA301AD5Q30578694-DDCD855A-1EED-4887-B07A-4199D6970139Q33230664-AB6A90EC-4FF5-439F-A64A-5A22E342944BQ33315576-A02618CB-92B0-4A43-BAFD-DC533A8C4A80Q33385456-EE10B504-7C41-484C-A89F-5F586B45FD65Q33417863-CE3F51AA-1E1B-4DB6-973C-0A22ACC503AFQ33508837-FDE63363-9F82-4022-BDE3-A1FD3E4F662DQ33509892-63506092-2A51-46E1-A37B-CC28A0791704Q33715990-BA9A2BF6-0AD2-4171-8C7B-85CD3688D427Q33815903-59F0A10D-F1A7-4545-9305-825C31C737D1Q33865096-AFF13D20-5DB5-446D-8AE4-7F581F890C59Q33933093-40ED4E60-8E5A-49B6-9169-0E6CE7B2AF41Q33947126-5226BDEC-1435-468D-A709-525FD89811E8
P2860
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@ast
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@en
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@nl
type
label
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@ast
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@en
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@nl
prefLabel
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@ast
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@en
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
@en
P2093
Edward M Haller
Huayan Hou
Santo V Nicosia
Wenlong Bai
Yonghua Yang
P2860
P304
P3181
P356
10.1038/SJ.EMBOJ.7600570
P407
P577
2005-03-09T00:00:00Z